liposomal irinotecan clinical trials
3 indexed studies · 2 currently recruiting
- RecruitingPHASE3
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
This study is testing a new drug called setidegrasib for people in the UK with advanced pancreatic cancer. It's for those whose cancer has spread and has a specific gene change (KRAS G12D). The study wants to see if adding setidegrasib to standard chemotherapy helps people live longer and feel better.
For: Pancreatic Cancer · Metastatic Pancreatic Cancer · Metastatic Pancreatic AdenocarcinomaUnited States · China · Japan - RecruitingPHASE1
A Study of ASP3082 in Adults With Advanced Solid Tumors
This study looks at a new drug, ASP3082, for adults with advanced solid cancers that have a specific genetic change called KRAS G12D. It checks how safe the drug is and what dose works best, sometimes with another drug called cetuximab.
For: Solid TumorUnited States · China · France - Active not recruitingPHASE3
Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
This study is looking for a new treatment for pancreatic cancer that has spread. It compares a new medicine called RMC-6236 with standard chemotherapy for people whose cancer has already been treated once before. The aim is to see if the new medicine is safer and works better.
For: Pancreatic Cancer · PDAC · PDAC - Pancreatic Ductal AdenocarcinomaUnited States · France · Germany